U.S. Household Products Stock News

Over the last 7 days, the United States market has remained flat, though it is up 20% over the past year and earnings are expected to grow by 17% per annum in the coming years. Penny stocks may be a throwback term, but they continue to offer intriguing opportunities for investors seeking growth at lower price points. When backed by strong financial health and solid fundamentals, these stocks can present unique chances for substantial returns without many of the risks typically associated with...

Customs intensive logistics stocks sit right in the crosshairs of a US crackdown on trade fraud, AI driven enforcement and a possible reset of USMCA rules. For investors, that mix can create both pressure and fresh openings as money and market share shift toward firms that handle complexity well. This article walks through 3 stocks exposed to that news, and how each might fit or not fit in your portfolio. The three customs intensive logistics stocks in this article are only a starting sample,...

In the past quarter, BioLife Solutions, Inc. reported second-quarter 2026 sales of US$28.47 million, up from US$23.44 million a year earlier, and moved from a net loss of US$15.84 million to net income of US$45.10 million, with basic earnings per share from continuing operations improving from a loss of US$0.32 to earnings of US$0.92. Over the first half of 2026, sales grew to US$55.97 million from US$45.49 million, and the shift from a US$16.29 million net loss to US$46.29 million in net...

Pharvaris (NasdaqGS:PHVS) has drawn fresh investor attention after publishing qualitative research on acquired C1 inhibitor deficiency angioedema. This work feeds directly into endpoint selection for its ongoing deucrictibant Phase 3 CREAATE study. See our latest analysis for Pharvaris. Against this backdrop, Pharvaris shares trade at $35.14, with a 90 day share price return of 21.38% and a year to date share price return of 32.70%. The 1 year total shareholder return of 58.57% and 3 year...

Earlier in August, Under Armour cut its full‑year outlook, now expecting mid‑single‑digit revenue decline, while Q1 2026 sales slipped to US$1,097.93 million but swung to a small net income of US$0.55 million. The company is prioritizing long‑term brand health through product and marketplace simplification even as softer demand in North America and Asia‑Pacific pressures near‑term results. Next, we'll examine how Under Armour's lowered full‑year revenue guidance could reshape its investment...

Cass Information Systems’ July data showed truckload linehaul rates rising even as freight volumes softened, while Schneider National recently reported double-digit gains on contract rate renewals and plans to redirect equipment from a departed dedicated customer into the spot market. Tighter truckload capacity and a shipper preference for higher-quality carriers appear to be reinforcing Schneider’s pricing power and operational flexibility. We’ll now consider how Schneider’s double-digit...

On August 11, 2026, Littelfuse, Inc. announced that Todd Kelsey, President and Chief Executive Officer of Plexus Corp., joined its board of directors and Compensation Committee, bringing decades of engineering and leadership experience across highly regulated technology markets. Kelsey’s background in complex product design, manufacturing and governance for sectors such as aerospace, industrial and healthcare is likely to add specialized operational and compensation oversight expertise to...

Kodiak Gas Services, Inc. has already reported past second-quarter 2026 results, posting revenue of US$391.12 million and net income of US$51.97 million, and its board declared a US$0.49 per-share cash dividend payable on August 27, 2026 to shareholders of record on August 17, 2026. The combination of higher sales and earnings per share alongside a maintained cash dividend highlights Kodiak’s ability to pair profit growth with ongoing cash returns to shareholders. We’ll now examine how this...

n2uitive Corporation previously announced the launch of its cloud-native accelerator for Guidewire ClaimCenter, with Erie Insurance Company among the first carriers to deploy the integration to streamline investigative recorded statements in claims handling. By automating the initiation, capture, and documentation of recorded statements directly within ClaimCenter, Erie can convert a formerly manual, error-prone process into a more consistent, defensible workflow across its claims...

The Meta trial over alleged harm to children has put a dollar figure on digital risk that runs from hundreds of billions to as high as $1.4t in potential penalties and forced product changes. That kind of legal shock can ripple into cyber liability and professional indemnity insurance. This article walks through three stocks exposed to this story and why their positioning could matter for your portfolio decisions. The three stocks covered next are only a starting sample of how tech litigation...

Rising global inflation risks linked to higher energy costs are pushing up bond yields and risk premiums. That shift keeps attention on sectors tied to government spending, where demand is often shaped more by policy than by consumer confidence. Aerospace and Defense stocks sit squarely in that camp. This article highlights three stocks from our Aerospace And Defense screener that can help you research this theme more effectively. The three Aerospace And Defense stocks covered below are only...

Sylvamo (SLVM) reported second quarter 2026 results that shifted from profit to loss, with sales of US$806 million and a net loss of US$11 million. This change could influence how investors view the stock. See our latest analysis for Sylvamo. The earnings setback appears to have weighed on sentiment, with Sylvamo’s share price falling 19.65% year to date and the 1-year total shareholder return down 8.54%. However, the 3-year total shareholder return remains positive at 10.30%. If Sylvamo’s...

In early August 2026, Polaris Off Road launched its model year 2027 lineup, highlighted by the 275-horsepower RZR Pro R Boost, NUMATIX pneumatic CVT in the XPEDITION, and the value-focused Sportsman 500 starting at US$6,999, with shipments to dealers scheduled from August to November 2026. This product wave combines high-performance innovation, quieter and more refined drivetrains, and cross-model accessory compatibility, potentially reshaping how Polaris balances premium features with...

With Fed policy uncertain, oil prices near $88 and Treasury yields edging higher, the stakes for U.S. consumer stocks feel especially high. Retail earnings over the next few weeks will act like a stress test for household budgets and sentiment. This article walks through three large U.S. consumer retail leaders that are closely tied to these cross currents and explains how the same headlines could create opportunity or risk for each stock. The three stocks in this article are just a starting...

Champion Homes, Inc. reported mixed first-quarter results for the period ended June 27, 2026, with sales rising to US$710.23 million from US$701.32 million a year earlier, while net income fell to US$49.16 million and diluted earnings per share from continuing operations eased to US$0.89 from US$1.13. On the same day, the company lifted its share repurchase authorization by US$50 million to a remaining US$150 million, signaling continued commitment to returning capital to shareholders even...

Why Rambus stock is in focus after the FMS 2026 conference Rambus (RMBS) heads into its Future of Memory and Storage 2026 presentation in Santa Clara with investors watching how new product commentary from product leaders might connect to the company’s current valuation profile. See our latest analysis for Rambus. Rambus shares trade at US$100.85 after a 1 day share price return of 1.53% and a 7 day share price return of 5.17%, although the 90 day share price return is down 17.36%. The 1 year...

In August 2026, Edding Genor Group disclosed that Syndax Pharmaceuticals had terminated its 2013 license with EOC Pharma, immediately ending all sublicenses for Jing Zhu Da and halting related commercialization arrangements in Mainland China. This termination not only suspends Eddingpharm’s planned cancer product rollout and linked commission streams, but also raises questions about how Syndax intends to handle access and partnerships for this asset in one of the world’s largest oncology...

More than US$100b in Trump era tariff refunds is starting to wash back through large U.S. importers, quietly reshaping earnings, cash flows, and even consumer pricing power. That mix of extra cash and still firm growth has created fresh openings in some corners of the market, while turning others into potential traps. This article walks through three large cap consumer facing stocks exposed to this news and what that might mean for your portfolio thinking. The stocks in the list below are...

XPO, Inc. announced that Jonas Svedlund joined the company as chief legal officer on August 10, 2026, to lead its legal and compliance, corporate governance and commercial matters after senior roles at Thermo Fisher Scientific, General Electric and law firm Sullivan & Cromwell. His appointment adds large-cap industrial and life sciences legal experience to XPO’s leadership bench at a time when regulatory, contractual and technology issues are increasingly central to freight operations. Next,...

UFP Technologies, Inc. reported past second-quarter 2026 results with sales of US$173.96 million and net income of US$20.85 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. For the first half of 2026, the company showed higher sales and net income than the prior year period, pointing to improved profitability and operating performance across its core business. With stronger year-on-year sales and earnings in both the quarter and...

ConnectOne Bancorp (CNOB) stock is in focus after recent trading data showed mixed short term moves and a stronger longer term record, which gives investors fresh context for assessing this regional bank. See our latest analysis for ConnectOne Bancorp. With the share price at about US$33.03, ConnectOne Bancorp has seen mixed short term trading. The 90 day share price return of 13.64% sits alongside a 26.44% year to date share price return and a 40.83% 1 year total shareholder return, which...

Restructuring playbooks that once sat inside private equity funds are now turning up in listed MedTech groups, with job cuts, asset sales and portfolio reviews all hitting the headlines at the same time as regulatory setbacks and fresh takeover interest. That mix can create sharp winners and quiet laggards. This article walks through three MedTech stocks exposed to these catalysts and explains how investors might think about the risks and potential rewards. The stocks covered in this article...

Novavax (NVAX) is back in focus after its latest quarterly report showed revenue of US$56.7 million and a swing from profit to a net loss, along with a new US$82.5 million shelf registration filing. See our latest analysis for Novavax. The latest results and shelf registration have landed against a mixed backdrop for Novavax, with the 1-day share price return down 1.11% but the year-to-date share price return up 12.90%, while the 1-year total shareholder return has declined 17.10%. If you are...

Bank of Hawaii (BOH) has drawn investor focus after recent trading left the stock at US$80.29. The move comes alongside mixed short term returns, with a gain over the past 3 months but a decline over the past month. See our latest analysis for Bank of Hawaii. Set against a 1-day share price return of 0.54% and a 7-day share price return of 2.03%, Bank of Hawaii’s 30-day share price return of 6.48% is weaker compared with its 17.35% year to date share price return and 28.70% 1-year total...